1Wasilewska M, Adamiec R. Cerebral regulation of insulin se- cretion and the development of insulin resistance in type 2 dia- betes[J ]. Adv Clin Exp Med, 2012, 21(6) : 695.
2Wilson C. Metabolism: Iron metabolism, adiponectin and T2DM - - the link with adipocyte insulin resistance[J]. Nat Rev Endocrino, 2012, 8(12): 696.
3Rosengren A H, Braun M, Mahdi T, et al. Reduced insulin exocytosis in human pancreatic 13 - ceils with gene variants linked to type 2 diabetes[J]. Diabetes, 2012, 61(7) : 1726.
4Relimpio F, Guerrero R, Martinez - Brocca M A. HbAlc levels are better predicted by prebreakfast than postbreakfast blood glucose self - analyss in type 2 diabetes. Influence of duration of diabetes and mode of treatment [ J ]. Acta Dia- betol, 2007, 44(2): 55.
5Boyle M E, Seifert K M, Beer K A, et al. Guidelines for ap- plication of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period[J]. J Diabetes Sci Technol, 2012, 6(1): 184.
6Rendell M, Akturk H K, Tella S H. Glargine safety, dia- betes and cancer[]. Expert Opin Drug Saf, 2013, 12(2): 247.
7Wu P, Ji C, Wang M, et al. Desensitization of allergy to hu- man insulin and its analogs by administering insulin aspart and insulin glargine[J ]. Ann Endocrinol (Paris), 2013, 74 ( 1 ) : 56.
8Ohta A, Arai K, Nishine A, et al. Comparison of daily glu- cose excursion by continuous glucose monitoring between type 2 diabetic patients receiving preprandial insulin aspart or post- prandial insulin glulisine[JJ. Endocr J, 2013, 60(2) : 173.
